← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 2004Last known activity
Jan 16, 2024
Timeline
1980s
- Jan 1, 1986
CONRAD— Founded
Drugs by trial phase (23 distinct, 48 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Phase 1 (8 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (50)
- NCT06274398OfficialPhase 1Jan 16, 2024
- NCT06274398CollaboratorPhase 1Jan 16, 2024
- NCT06087913CollaboratorPhase 1Nov 8, 2023
- NCT05458765CollaboratorPhase 2Jun 21, 2022
- NCT05458765Overall official - principal investigatorPhase 2Jun 21, 2022
- NCT05458765Study directorPhase 2Jun 21, 2022
- NCT04814927CollaboratorPhase 4Mar 1, 2021
- NCT04066881CollaboratorPhase 2Jan 31, 2020
- NCT04195776CollaboratorPhase 1Jan 1, 2020
- NCT04047420CollaboratorPhase 1Oct 31, 2019
- NCT03762382Lead sponsorPhase 2Dec 12, 2018
- NCT03762772Study directorPhase 1Dec 10, 2018
- NCT03762772Lead sponsorPhase 1Dec 10, 2018
- NCT03279120Lead sponsorPhase 1Sep 28, 2017
- NCT02904369Lead sponsorPhase 1Oct 1, 2016
Details
- Founded
- Arlington, VA, US Jan 1, 1986
- Last known activity
- Jan 16, 2024